Cor Vasa 2009, 51(7-8):470-477 | DOI: 10.33678/cor.2009.120
Pulmonary hypertension in congenital heart disease
- Kardiocentrum, Oddělení kardiochirurgie, Nemocnice Na Homolce, Praha, Česká republika
In our series of 2,300 adult patients with congenital heart disease (CHD), pulmonary hypertension (PH) was diagnosed in 5.8%. Ventricular septal defect was diagnosed in 36% of our PH patients, atrial septal defect in 26%, complex CHD in 12%, atrioventricular septal defect in 11%, patent ductus arteriosus in 6%, and coarctation of the aorta in 3%. Eisenmenger's syndrome was present in 28% in PH patients, with 10-year mortality from Eisenmenger's syndrome being 18%. To date, we have operated on 52 patients with CHD and PH (39% of all PH patients), with a mortality rate of 3.8%. Conservative measures are very important for inoperable patients with PH. Venepuncture is generally not indicated in patients with Eisenmenger's syndrome. In some patients, symptoms can be improved by specific vasodilator. Our experience is compared with that reported in the relevant literature.
Keywords: Congenital heart disease; Pulmonary hypertension; Eisenmenger's syndrome; Pulmonary vasodilator therapy; Surgery in pulmonary hypertension
Published: July 1, 2009 Show citation
References
- Therrien J, Warnes C, Daliento L, et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part III. Can J Cardiol 2001;17: 1135-58.
- Popelová J, Oechslin E, Kaemmerrer H, Sutton MSJ. Congenital heart disease in adults. London: Informa UK Ldt., 2008:145-55.
Go to original source...
- Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects: results of treatment of patients with ventricular septal defects. Circulation 1993;87 (Suppl 2):I38-51.
Go to PubMed...
- Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-50.
Go to original source...
Go to PubMed...
- Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Duch registry. Int J Cardiol 2007;120:198-204.
Go to original source...
Go to PubMed...
- Engelfriet PM, Duffels MG, Möller T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 2007;93:682-7.
Go to original source...
Go to PubMed...
- Galie N, Manes A, Palazzini M, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs 2008;68:1049-66.
Go to original source...
Go to PubMed...
- Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958;II:701-9, 755-62.
Go to original source...
- Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000;86:1111-6.
Go to original source...
- Roberts KE, McElroy JJ, Wong WP, et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004;24: 371-4.
Go to original source...
Go to PubMed...
- Engelfrie P, Boersma E, Oechslin E, et al. The spectrum of Adult Congenital heart Disease in Europe: Morbidity and mortality in a 5-year follow-up period. Eur Heart J 2005,26:2325-33.
Go to original source...
Go to PubMed...
- Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999; 84:677-81.
Go to original source...
Go to PubMed...
- Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998;19:1845-55.
Go to original source...
Go to PubMed...
- Hopkins WE, Ochoa LL, Richardson, GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger's syndrome. J Heart Lung Transplant 1996;15:100-5.
- Stewart S. Pulmonary arterial hypertension. Oxion: Taylor and Francis, 2005:9.
Go to original source...
Go to PubMed...
- Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease. Circulation 2008;118:e714-e833.
Go to original source...
- McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the American heart Association. J Am Coll Cardiol 2009;53:1573-619.
Go to original source...
Go to PubMed...
- Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left-ventricular end-diastolic pressure. Chest 2009;v tisku.
Go to original source...
- Bando K, Turrentine MW, Sharp TG. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factor and management. J Thorac Cardiovacs Surg 1996;112:1600-9.
Go to original source...
Go to PubMed...
- Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 2002;40:789-95.
Go to original source...
Go to PubMed...
- Cesnjevar RA, Feyrer R, Walther F, et al. High-risk mitral valve replacement in severe pulmonary hypertension - 30 years experience. Eur J Cardio-Thoracic Surg 1998;13:344-52.
Go to original source...
Go to PubMed...
- Frost AE, Quinones MA, Zoghbi WA, Noon GP. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant 2005;24:501-3.
Go to original source...
Go to PubMed...
- Schwerzmann M, Zafar M, McLaughlin PR, et al. Atrial septal defect closure in a patient with irreversible pulmonary hypertensive arteriopathy. Int J Cardiol 2006;110:104-7.
Go to original source...
Go to PubMed...
- Somerville J. How to manage the Eisenmenger syndrome. Int J Cardiol 1998;63:1-8.
Go to original source...
Go to PubMed...
- Popelová J. Vrozené srdeční vady v dospělosti. Praha: Grada, 2003: 253-66.
- Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-11.
Go to original source...
Go to PubMed...
- Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome. A multicenter, double blind, randomized, placebo-controlled study (BREATHE-5). Circulation 2006;114:48-54.
Go to original source...
Go to PubMed...
- Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated cogenital heart defects. Circulation 1999; 99:1858-65.
Go to original source...
- Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger's physiology. Am J Cardiol 2003;91:632-5.
Go to original source...
- Simonneau G, Barst RJ, Galie N. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension. A double-blind, randomized, placebo-controlled trial. Am J Resp Crit Care Med 2002;165:800-4.
Go to original source...
Go to PubMed...
- Gatzoulis MA, Beghetti M, Galie N, et al. Long-term bosentan therapy improves functional capacity in Eisenmenger's syndrome: result of the BREATHE-5 open-label extension study. Int J Cardiol 2008;127:27-32.
Go to original source...
Go to PubMed...
- vanLoon RLE, Hoendermis ES, Duffels MG, et al. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J 2007;154:776-82.
Go to original source...
Go to PubMed...
- Brun H, Thaulow E, Fredriksen PM, Holmstrom H. Treatment of patients with Eisenmenger's syndrome with bosentan. Cardiol Young 2007;17: 288-94.
Go to original source...
Go to PubMed...
- Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin - a receptor antagonist sitaxsentan. J Am Coll Cardiol 2006;47:2049-56.
Go to original source...
Go to PubMed...
- Nagendran J, Archer SL, Soliman D, et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007;116:238-48.
Go to original source...
Go to PubMed...
- Palazzini M, Manes A,Romanayyi S, et al. Effects of sildenafil treatment in patients with pulmonary hypertension associated with congenital cardiac shunts (Abstract). Eur Heart J 2007;28:308.
- Goerler H, Simon A, Gohrbandt B, et al. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardio-Thorac Surg 2007;32:926-31.
Go to original source...
Go to PubMed...
- Harada Y, Uchita S, Sakamoto T, et al. Do we need fenestration when performing two-staged total cavopulmonary connection using an extracardiac conduit? Inter Cardio-Thoracic Surg 2009; v tisku.
Go to original source...